HEALEY ALS Platform Trial Updates and April 8 Webinar
We are closely monitoring the impact of COVID-19 on the HEALEY ALS Platform Trial timeline. We are committed to starting as soon as we can do so safely, and will be hosting a webinar on April 8th to provide as many details as possible.
Accelerating Discovery with the HEALEY ALS Platform Trial
Borrowing from successes in cancer drug development, Healey Center and NEALS faculty are leading the first ALS Platform Trial.
Igniting Innovation Through Research & Trials
The Healey Center for ALS unites the world’s leading experts to revolutionize how treatments are developed for people with amyotrophic lateral sclerosis (ALS). We support and accelerate groundbreaking, innovative global clinical trials for all people with ALS.